Network origin in Marcia Taylor first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
DeNovaMed, Inc.
 DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology DeNovaMed, Inc. develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs. It focuses in the areas of Gram-positive infections, methicillin-resistant Staph and vancomycin-resistant Enterococcus pose a threat to patients in hospitals and community health facilities by producing skin, wound and systemic infections. The firm also has an ongoing discovery program for Gram-negative adjuvants, which can improve the efficacy of older antibacterial. The company was founded by Donald F. Weaver, Christopher R. McMaster and David Byers in 2006 and is headquartered in Halifax, Canada.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Marcia Taylor via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Dalhousie University | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| APPILI THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Treventis Corp.
 Treventis Corp. BiotechnologyHealth Technology Treventis Corp. develops a small molecule drugs for Alzheimer's and other protein misfolding diseases. It developed a proprietary discovery platform, a high-resolution three-dimensional model of the common conformational region, enabling rational design of multiple lead compounds. The company was founded by Christopher J. Barden, Donald F. Weaver and Sultan Darvesh in 2008 and is headquartered in Toronto, Canada. | Biotechnology | Founder Chief Executive Officer | |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Pharmaceuticals: Major | Chief Operating Officer | |
viDA Therapeutics, Inc.
 viDA Therapeutics, Inc. BiotechnologyHealth Technology viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal | |
| Johns Hopkins Bloomberg School of Public Health | College/University | Graduate Degree | |
| Uniformed Services University of the Health Sciences | College/University | Corporate Officer/Principal | |
| Haffner Associates LLC | Chief Executive Officer | ||
Neurochem (International) Ltd.
 Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland. | Miscellaneous Commercial Services | Founder | |
| Canada Research Chairs Program | General Government | Corporate Officer/Principal | |
Covina Biomedical, Inc.
 Covina Biomedical, Inc. Medical SpecialtiesHealth Technology Covina Biomedical, Inc. manufactures orthopedic medical devices. The private company is based in Halifax, Canada. | Medical Specialties | Director/Board Member | |
Audioptics Medical, Inc.
 Audioptics Medical, Inc. Medical SpecialtiesHealth Technology Audioptics Medical, Inc. engages in the development of endoscope for clinical otology. The company was founded on December 15, 2016 and is headquartered in Halifax, Canada. | Medical Specialties | Director/Board Member | |
| Canada's Venture Capital & Private Equity Association | Director/Board Member | ||
BioTalent Canada
 BioTalent Canada Miscellaneous Commercial ServicesCommercial Services BioTalent Canada is a non-profit organization, which focuses on building partnerships and skills for Canada?s bio-economy to ensure the industry has access to job-ready people. It connects employers with job seekers, delivers human resource information, and skills development tools so the biotech industry through projects, research and product development .The company is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
MedInnova Partners, Inc.
 MedInnova Partners, Inc. Investment ManagersFinance MedInnova Partners, Inc is a venture capital firm, founded in 2000. The firm headquartered in Halifax, Nova Scotia. | Investment Managers | Corporate Officer/Principal | |
| McMaster University | College/University | Masters Business Admin | |
| University of Zagreb | College/University | Doctorate Degree | |
Innovacorp
 Innovacorp Investment ManagersFinance Innovacorp is an independent venture capital firm founded in 1995. The firm is headquartered in Halifax, Nova Scotia, Canada. | Investment Managers | Private Equity Investor | |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Private Equity Analyst | |
| Qing Bile Therapeutics, Inc. | Director/Board Member | ||
| Richard Ivey School of Business | College/University | Masters Business Admin | |
| George Washington University | College/University | Doctorate Degree |
Statistics
International
| Canada | 20 |
| United States | 7 |
| Israel | 2 |
| Switzerland | 2 |
| Croatia | 2 |
Sectoral
| Health Technology | 11 |
| Consumer Services | 8 |
| Finance | 4 |
| Government | 3 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 15 |
| Corporate Officer/Principal | 13 |
| Founder | 6 |
| Chief Executive Officer | 4 |
| Chief Operating Officer | 3 |
Most connected contacts
- Stock Market
- Insiders
- Marcia Taylor
- Company connections
